Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Aggression × Dexamethasone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 707 Precursor Cell Lymphoblastic Leukemia-Lymphoma 149 Recurrence 118 Neoplasms, Plasma Cell 100 Lymphoma 84 Leukemia 83 Neoplasms 74 Vomiting 49 Burkitt Lymphoma 49 Lymphoma, Non-Hodgkin 44 Immunoglobulin Light-chain Amyloidosis 42 Lymphoma, Mantle-Cell 36 Lymphoma, Large B-Cell, Diffuse 36 Nausea 33 Prostatic Neoplasms 29 Lymphoma, Follicular 28 Waldenstrom Macroglobulinemia 27 Hodgkin Disease 27 Leukemia, Myeloid, Acute 25 Breast Neoplasms 25 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 23 Neoplasm Metastasis 23 Leukemia, Lymphocytic, Chronic, B-Cell 23 Carcinoma, Non-Small-Cell Lung 22 Lung Neoplasms 20 Amyloidosis 16 Lymphoma, Extranodal NK-T-Cell 15 Lymphoma, B-Cell, Marginal Zone 15 Leukemia, Biphenotypic, Acute 14 Smoldering Multiple Myeloma 13

Interventions

selinexor 1 pegfilgrastim 1 midostaurin 1 glofitamab 1 Topotecan 1 Rituximab 1 Prednisone 1 Paclitaxel 1 Methylprednisolone 1 Immunologic Techniques 1 Ifosfamide 1 Flow Cytometry 1 Etoposide 1 Dexamethasone 1 Clofarabine 1 Carboplatin 1 Alemtuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02471911 2022-04-12

KPT-330+RICE

Weill Medical College of Cornell University

Phase 1 Completed

Aggression, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡